Optimizing surrogate end points for preoperative systemic therapies in non-small cell lung cancers.
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, wnwillia@mdanderson.org.
William N
WN
William
Stephen G
SG
Swisher
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D020360:Neoadjuvant Therapy; D018579:Patient Selection; D011300:Preoperative Care
D000970:Antineoplastic Agents; D015415:Biomarkers